Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2025-09-22 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于公司总裁、副总裁辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's president and vice president. It details the changes in senior management positions and confirms no outstanding commitments or shareholdings by the resigning officers. There is no financial data, report publication, or voting results involved. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-09-22 Chinese
关于启迪药业集团股份公司2025年第一次临时股东大会的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the procedural legality of a company's 2025 first extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the meeting. The document does not contain financial statements or management discussion but focuses on the legality and validity of the shareholder meeting and its resolutions. This type of document is a legal opinion related to a shareholder meeting, not the meeting materials themselves or the voting results announcement. It is not an Annual Report, Interim Report, or Earnings Release. It is not a Proxy Solicitation or Voting Results Declaration. Given the nature of the document as a legal opinion on the shareholder meeting, it fits best under Legal Proceedings Report (LTR), which covers updates on legal matters involving the company, including legal opinions on corporate governance events.
2025-09-22 Chinese
关于2025年第一次临时股东大会取消部分提案暨股东大会的补充通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the cancellation of certain proposals and supplementary notice for the 2025 first extraordinary general meeting (临时股东大会) of the company 启迪药业集团股份公司. It includes information about meeting dates, voting procedures, proposal details, and proxy forms. The content focuses on shareholder meeting logistics and voting instructions rather than financial results or management reports. It is not a full annual or interim report, earnings release, or audit report. It is not a proxy solicitation statement but rather a notice about the meeting and changes to proposals. Therefore, it fits best as a Declaration of Voting Results & Voting Rights Announcements (DVA) or a Proxy Solicitation & Information Statement (PSI). However, since it is about cancellation of proposals and supplementary notice for the meeting, it is more aligned with Proxy Solicitation & Information Statement (PSI) which covers materials sent to shareholders to provide information and request votes for meetings. The document length and detail also support PSI rather than a short announcement (RPA).
2025-09-16 Chinese
第十届董事会临时会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 10th Board of Directors' extraordinary meeting of the company. It details the cancellation of certain proposals for the upcoming extraordinary general meeting, specifically the proposal to change the company name and amend the articles of association. The document includes voting results and references compliance with company bylaws and regulations. It does not contain financial statements, audit information, or detailed management discussion. It is a formal announcement related to board decisions and changes in proposals for shareholder meetings, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or presentation but an official announcement of board meeting resolutions.
2025-09-16 Chinese
2025年第一次临时股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as materials for the "2025 First Extraordinary General Meeting of Shareholders" and includes detailed agenda items such as proposals for related party transactions, change of accounting firm, and election of board members. It contains comprehensive information typically presented to shareholders before or during a shareholders' meeting, including voting procedures, candidate biographies, and explanations of proposals. The content is not a report itself but rather the meeting materials for a shareholders' meeting. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting. The document length is over 8,000 characters, indicating it is substantive meeting materials rather than a brief announcement or notice. Therefore, the correct classification is AGM Information (AGM-R).
2025-09-16 Chinese
关于参加2025年湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会活动的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the company's participation in an investor online collective reception day and a half-year performance explanation meeting. It mentions the event date and the company's management will interact with investors online. The document is short (525 characters) and does not contain any financial statements or detailed financial data. It is an announcement of an event related to investor communication rather than the actual report or transcript. Therefore, it fits best as an Investor Presentation (IP) announcement or related event notice. However, since it is an announcement of participation in an investor event rather than the presentation itself, and given the options, the closest classification is Investor Presentation (IP). Confidence is high due to clear event description and lack of financial data.
2025-09-12 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.